中文 | English
Return
Total: 37 , 1/4
Show Home Prev Next End page: GO
MeSH:(Azacitidine/therapeutic use*)

2.Efficacy and Safety of Different Dosages of Decitabine in the Treatment of High-Risk Patients with Myelodysplastic Syndrome.

Chun TONG ; Fang YE ; Ning-Ning LI ; Huan WANG ; Ya-Nan SHU ; Ling WANG ; Li-Nan ZHANG

Journal of Experimental Hematology 2021;29(6):1845-1850

4.Short-term efficacy of venetoclax combined with azacitidine in acute myeloid leukemia: a single-institution experience.

Wen Jing YU ; Jin Song JIA ; Jing WANG ; Fei Fei TANG ; Li Zhong GONG ; Xiao Hong LIU ; Xiao Lu ZHU ; Xiao Su ZHAO ; Xiao Jun HUANG ; Hao JIANG

Chinese Journal of Hematology 2022;43(2):134-140

6.Safety and the Short-Term Efficacy of Venetoclax Combined with Azacitidine Followed by Cladribine in Children with Refractory/Relapsed Acute Myeloid Leukemia.

Wei-Wei DU ; Su-Xiang LIU ; Yi WANG ; Hai-Long HE ; Ai-Lian GUO ; Shao-Yan HU ; Jun LU

Journal of Experimental Hematology 2023;31(6):1635-1638

8.Decitabine for treatment of myelodysplastic syndrome in an elderly patient and review of literature.

Ya GAO ; Baohong PING ; Shuyun ZHOU

Journal of Southern Medical University 2012;32(2):280-282

9.Efficacy and Safety of Decitabine Combined with Half-Course Pre-excitation for the Treatment of Elderly Patients with Acute Myeloid Leukemia.

Hong-Chun QIU ; Rong KONG ; Peng-Fei WU ; Yong WANG ; Xing-Li ZHANG ; De-Hong WU ; Qian LIU

Journal of Experimental Hematology 2019;27(5):1431-1435

10.Efficacy of Venetoclax Plus Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia Patients with FLT3-ITD Mutation.

Guang-Yang WENG ; Wei-Wen YOU ; Huan-Xun LIU ; Yun CAI ; Xin DU

Journal of Experimental Hematology 2023;31(5):1333-1339

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 37 , 1/4 Show Home Prev Next End page: GO